Researchers have found the first evidence that non-human animals can mentally replay past events from memory. The discovery could help advance the development of new drugs to treat Alzheimer’s disease.
Researchers have learned that artificial intelligence resembles the working of a human brain, opening up new possibilities to test how the brain works.
For the first time, a human mini brain has been implanted into the skull of mice and surprisingly has continued to grow.
Studies using CRISPR on monkeys look encouraging, but more needs to be done before the gene-editing technology can be used on humans.
A drug combination has been discovered that could potentially reverse disease symptoms by adjusting natural cellular functions.
Researchers have used CRISPR to develop a pig model of Huntington’s disease that better mimics how the disease progresses in humans.
For years scientists have been trying to conquer the aging process, but after a few setbacks and stumbles, it seems they have come the closest they have ever got.
When researchers tested the susceptibility of mice lacking calnexin to a mouse model of human MS (experimental autoimmune encephalomyelitis), they were astonished to find that the mice were completely resistant to the disease.
Researchers have developed a gene therapy that successfully treats a form of macular degeneration in a canine model. Following safety studies, a human clinical trial could be less than two years away.
To unearth new functional regions in the human genome with potential roles in shaping clinically important traits, researchers are using animals with extraordinary traits to reveal new elements.